Predictors of reincarceration and disease progression among released HIV-infected inmates

Jacques Baillargeon, Thomas P. Giordano, Amy Jo Harzke, Anne C. Spaulding, Z. Helen Wu, James J. Grady, Gwen Baillargeon, David P. Paar

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

We conducted a retrospective cohort study to determine the 3-year reincarceration rate of all HIV-infected inmates (n=1917) released from the Texas prison system between January 2004 and March 2006. We also analyzed postrelease changes in HIV clinical status in the subgroup of inmates who were subsequently reincarcerated and had either CD4 lymphocyte counts (n=119) or plasma HIV RNA levels (n=122) recorded in their electronic medical record at both release and reincarceration. Multivariable analyses were performed to assess predictors of reincarceration and clinical changes in HIV status. Only 20% of all HIV-infected inmates were reincarcerated within 3 years of release. Female inmates (hazard ratio [HR] 0.63; 95% confidence interval [CI], 0.47, 0.84) and inmates taking antiretroviral therapy at the time of release (HR 0.31; 95% CI, 0.25, 0.39) were at decreased risk of reincarceration. African Americans (HR 1.58; 95% CI, 1.22, 2.05), inmates with a major psychiatric disorder (HR 1.82; 95% CI, 1.41, 2.34), and inmates released on parole (HR 2.86; 95% CI, 2.31, 3.55) were at increased risk of reincarceration. A subgroup of reincarcerated inmates had a mean decrease in CD4 cell count of 79.4 lymphocytes per microliter (p<0.0003) and a mean increase in viral load of 1.5 log 10 copies per milliliter (p<0.0001) in the period between release and reincarceration. Our findings, although substantially limited by selection bias, highlight the importance of developing discharge planning programs to improve linkage to community-based HIV care and reduce recidivism among released HIV-infected inmates.

Original languageEnglish (US)
Pages (from-to)389-394
Number of pages6
JournalAIDS Patient Care and STDs
Volume24
Issue number6
DOIs
StatePublished - Jun 1 2010

Fingerprint

Disease Progression
HIV
Confidence Intervals
CD4 Lymphocyte Count
Selection Bias
Patient Discharge
Electronic Health Records
Prisons
Viral Load
African Americans
Psychiatry
Cohort Studies
Retrospective Studies
Lymphocytes
RNA

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Baillargeon, J., Giordano, T. P., Harzke, A. J., Spaulding, A. C., Wu, Z. H., Grady, J. J., ... Paar, D. P. (2010). Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care and STDs, 24(6), 389-394. https://doi.org/10.1089/apc.2009.0303

Predictors of reincarceration and disease progression among released HIV-infected inmates. / Baillargeon, Jacques; Giordano, Thomas P.; Harzke, Amy Jo; Spaulding, Anne C.; Wu, Z. Helen; Grady, James J.; Baillargeon, Gwen; Paar, David P.

In: AIDS Patient Care and STDs, Vol. 24, No. 6, 01.06.2010, p. 389-394.

Research output: Contribution to journalArticle

Baillargeon, J, Giordano, TP, Harzke, AJ, Spaulding, AC, Wu, ZH, Grady, JJ, Baillargeon, G & Paar, DP 2010, 'Predictors of reincarceration and disease progression among released HIV-infected inmates', AIDS Patient Care and STDs, vol. 24, no. 6, pp. 389-394. https://doi.org/10.1089/apc.2009.0303
Baillargeon, Jacques ; Giordano, Thomas P. ; Harzke, Amy Jo ; Spaulding, Anne C. ; Wu, Z. Helen ; Grady, James J. ; Baillargeon, Gwen ; Paar, David P. / Predictors of reincarceration and disease progression among released HIV-infected inmates. In: AIDS Patient Care and STDs. 2010 ; Vol. 24, No. 6. pp. 389-394.
@article{fe935e32a2774ed3bcb136bed6acaa40,
title = "Predictors of reincarceration and disease progression among released HIV-infected inmates",
abstract = "We conducted a retrospective cohort study to determine the 3-year reincarceration rate of all HIV-infected inmates (n=1917) released from the Texas prison system between January 2004 and March 2006. We also analyzed postrelease changes in HIV clinical status in the subgroup of inmates who were subsequently reincarcerated and had either CD4 lymphocyte counts (n=119) or plasma HIV RNA levels (n=122) recorded in their electronic medical record at both release and reincarceration. Multivariable analyses were performed to assess predictors of reincarceration and clinical changes in HIV status. Only 20{\%} of all HIV-infected inmates were reincarcerated within 3 years of release. Female inmates (hazard ratio [HR] 0.63; 95{\%} confidence interval [CI], 0.47, 0.84) and inmates taking antiretroviral therapy at the time of release (HR 0.31; 95{\%} CI, 0.25, 0.39) were at decreased risk of reincarceration. African Americans (HR 1.58; 95{\%} CI, 1.22, 2.05), inmates with a major psychiatric disorder (HR 1.82; 95{\%} CI, 1.41, 2.34), and inmates released on parole (HR 2.86; 95{\%} CI, 2.31, 3.55) were at increased risk of reincarceration. A subgroup of reincarcerated inmates had a mean decrease in CD4 cell count of 79.4 lymphocytes per microliter (p<0.0003) and a mean increase in viral load of 1.5 log 10 copies per milliliter (p<0.0001) in the period between release and reincarceration. Our findings, although substantially limited by selection bias, highlight the importance of developing discharge planning programs to improve linkage to community-based HIV care and reduce recidivism among released HIV-infected inmates.",
author = "Jacques Baillargeon and Giordano, {Thomas P.} and Harzke, {Amy Jo} and Spaulding, {Anne C.} and Wu, {Z. Helen} and Grady, {James J.} and Gwen Baillargeon and Paar, {David P.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1089/apc.2009.0303",
language = "English (US)",
volume = "24",
pages = "389--394",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Predictors of reincarceration and disease progression among released HIV-infected inmates

AU - Baillargeon, Jacques

AU - Giordano, Thomas P.

AU - Harzke, Amy Jo

AU - Spaulding, Anne C.

AU - Wu, Z. Helen

AU - Grady, James J.

AU - Baillargeon, Gwen

AU - Paar, David P.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - We conducted a retrospective cohort study to determine the 3-year reincarceration rate of all HIV-infected inmates (n=1917) released from the Texas prison system between January 2004 and March 2006. We also analyzed postrelease changes in HIV clinical status in the subgroup of inmates who were subsequently reincarcerated and had either CD4 lymphocyte counts (n=119) or plasma HIV RNA levels (n=122) recorded in their electronic medical record at both release and reincarceration. Multivariable analyses were performed to assess predictors of reincarceration and clinical changes in HIV status. Only 20% of all HIV-infected inmates were reincarcerated within 3 years of release. Female inmates (hazard ratio [HR] 0.63; 95% confidence interval [CI], 0.47, 0.84) and inmates taking antiretroviral therapy at the time of release (HR 0.31; 95% CI, 0.25, 0.39) were at decreased risk of reincarceration. African Americans (HR 1.58; 95% CI, 1.22, 2.05), inmates with a major psychiatric disorder (HR 1.82; 95% CI, 1.41, 2.34), and inmates released on parole (HR 2.86; 95% CI, 2.31, 3.55) were at increased risk of reincarceration. A subgroup of reincarcerated inmates had a mean decrease in CD4 cell count of 79.4 lymphocytes per microliter (p<0.0003) and a mean increase in viral load of 1.5 log 10 copies per milliliter (p<0.0001) in the period between release and reincarceration. Our findings, although substantially limited by selection bias, highlight the importance of developing discharge planning programs to improve linkage to community-based HIV care and reduce recidivism among released HIV-infected inmates.

AB - We conducted a retrospective cohort study to determine the 3-year reincarceration rate of all HIV-infected inmates (n=1917) released from the Texas prison system between January 2004 and March 2006. We also analyzed postrelease changes in HIV clinical status in the subgroup of inmates who were subsequently reincarcerated and had either CD4 lymphocyte counts (n=119) or plasma HIV RNA levels (n=122) recorded in their electronic medical record at both release and reincarceration. Multivariable analyses were performed to assess predictors of reincarceration and clinical changes in HIV status. Only 20% of all HIV-infected inmates were reincarcerated within 3 years of release. Female inmates (hazard ratio [HR] 0.63; 95% confidence interval [CI], 0.47, 0.84) and inmates taking antiretroviral therapy at the time of release (HR 0.31; 95% CI, 0.25, 0.39) were at decreased risk of reincarceration. African Americans (HR 1.58; 95% CI, 1.22, 2.05), inmates with a major psychiatric disorder (HR 1.82; 95% CI, 1.41, 2.34), and inmates released on parole (HR 2.86; 95% CI, 2.31, 3.55) were at increased risk of reincarceration. A subgroup of reincarcerated inmates had a mean decrease in CD4 cell count of 79.4 lymphocytes per microliter (p<0.0003) and a mean increase in viral load of 1.5 log 10 copies per milliliter (p<0.0001) in the period between release and reincarceration. Our findings, although substantially limited by selection bias, highlight the importance of developing discharge planning programs to improve linkage to community-based HIV care and reduce recidivism among released HIV-infected inmates.

UR - http://www.scopus.com/inward/record.url?scp=77954209901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954209901&partnerID=8YFLogxK

U2 - 10.1089/apc.2009.0303

DO - 10.1089/apc.2009.0303

M3 - Article

C2 - 20565323

AN - SCOPUS:77954209901

VL - 24

SP - 389

EP - 394

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 6

ER -